If 2023’s criminal investigations and civil actions under the federal Anti-Kickback Statute (AKS) and the False Claims Act (FCA) are any indication of what is to come from the DOJ in 2024, professionals and business owners occupying the medical space should buckle up and tread lightly.
Over the last several years, the DOJ has steadily upheld its commitment to pursue AKS and FCA violation's and rid corruption from the healthcare industry. The activity throughout 2023 certainly has grown the DOJ’s brag list – and the momentum does not seem to be letting up any time soon.
Click here to view the full article